We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Santarus Ulcerative Colitis Drug to Hit Shelves in March
Santarus Ulcerative Colitis Drug to Hit Shelves in March
January 18, 2013
The FDA has approved Santarus’ daily extended-release drug Uceris to induce remission of mild to moderate active ulcerative colitis, a form of inflammatory bowel disease.